Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02538094 · ClinicalTrials.gov registry record · NA

tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT02538094: Completed NA study, sponsored by Johns Hopkins University.

NCT02538094 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02538094, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities in individuals with multiple sclerosis (MS) or encephalitis. Participants will be asked to come in daily for two full weeks during which time participants will undergo cognitive testing and Magnetic Resonance Imaging (MRI) brain scans. In this research, a very weak electrical current is administered to the surface of the scalp while participants complete cognitive tasks. The investigators' aim is to find out whether tDCS will improve task performance in adults with multiple sclerosis or encephalitis.

Interventions

  • DEVICE Sham Transcranial direct current stimulation
  • DEVICE Anodal Transcranial direct current stimulation

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2014-09
Est. Completion 2019-06-30
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT02538094

The ClinicalTrials.gov registry entry for NCT02538094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham Transcranial direct current stimulation is the first listed.

NCT02538094 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02538094 about?

NCT02538094 is a clinical study titled "tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis". This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities in individuals with multiple sclerosis (MS) or encephalitis. Participants will be asked to come in daily for two full weeks during which time participants will undergo...

What is the current status of trial NCT02538094?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT02538094?

The interventions under investigation include: Sham Transcranial direct current stimulation (DEVICE), Anodal Transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT02538094?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.